Technical analysis · daily indicators as of 20 Nov 2026
84.16
+1.94 (+2.36%)
In short
Shukra Medtech has risen 94.2% in 3 months and made a new 52-week high (₹84.80). It is overbought (RSI 81.5).
New 52-week highOverbought
Price chart
Drag to measure a move, wheel or pinch to zoom
The verdict
The main signals
4/10
Mixed
Weakest on dividends.
Valueno data
P/E below its industry's
P/E below the market's (F&O stocks)
Price to book below its industry's
Price to sales below its industry's
P/E below its profit growth rate (PEG under 1)
Past performanceno data
Profit grew over the last 12 months
Profit grew over 3 years
Last year's profit growth beat its long-term average
Return on equity 15% or more
Sales grew over the last 12 months
Financial health3/5
Profitable over the last 12 months
Shareholders' equity is positive
Debt below equity
Debt below 40% of equity
Cash covers debt
Dividends1/5
Pays a dividend
Yield above the lowest quarter of Indian dividend payers
Yield in the top quarter of Indian dividend payers
Dividend covered by profit (payout under 90%)
Yield above its industry's
✓ Rewards
None found in our checks.
! Risks
Price moves more than 90% of F&O stocks
1-year return
+103.2%
Industry – · Nifty 50 -0.4%
Daily price swing
4.1%
Calm 2.1%Wild 3.7%
Beta vs Nifty 50
–
Not enough history
Dividend yield
0.01%
₹0.01 a share a year
Returns against the market
Last 7 days
Shukra Medtech
+2.3%Nifty 50
+2.6%
Last year
Shukra Medtech
+103.2%Nifty 50
-0.4%
Industry = the middle stock of the same NSE industry. Price returns, dividends not added back.
Price history ₹84.16 today
52-week low ₹40.06high ₹84.80
1 month+34.6%
3 months+94.2%
1 year+103.2%
Since 2026+103.2%
Who owns and trades it
Promoters 51.15%FIIs 0.44%DIIs 0.22%Public 48.19%
Shareholding at the end of the quarter to 2026-09-30, from the company's filings with the exchange.
InsidersInsider trades are loading: see the News tab.Insider trades ›
Bulk & block dealsNone in the last 30 days.Deals ›
About Shukra Medtech
Shukra Medtech is a small-cap company, worth about ₹3,710 crore on the market. Its debt is 0.19 times its equity. Promoters own 51.2% of the company. Its share price history on NSE goes back to 2026.
Small cap · ₹3,710 CrNSEPrice history from 2026Ticker SHUKRAMED
Momentum
RSI (14)
81.5Overbought
MACD (12, 26, 9)
4.47Below signal
Stochastic %K
79.3Neutral
ADX (14)
39.5Strong trend
Trend
Price vs SMA 20
79.18Above
Price vs SMA 50
68.77Above
Supertrend
73.49Bullish
Volatility & volume
Moving averages
Period
SMA
EMA
Crossovers
Candlestick patterns
On the last daily candle
Activity
Delivery
Last 20 trading days
Key levels in price order, today highlighted
52-week range
Low 40.06High 84.80
Breakouts & range
What these levels mean
R1–R3 are resistance above and S1–S3 support below, from the last session's high, low and close. How pivot points work ›
Based on 5 common daily signals (moving averages, RSI, MACD and Supertrend), Shukra Medtech's technical rating is "Strongly bullish" with 4 of 5 signals bullish. This is information only, not a recommendation.
What is the RSI of Shukra Medtech?
Shukra Medtech's 14-day RSI is 81.5 as of the 2026-11-20 close. Below 30 is usually called oversold and above 70 overbought.
What are Shukra Medtech's support and resistance levels?
Using classic pivot points from the last session: support S1 81.37, S2 78.59; resistance R1 85.87, R2 87.59.
What is Shukra Medtech's market cap and P/E?
Market cap ₹3,710 crore, from today's price and the last 12 months of results filed with NSE.
Technical ratings summarise common indicators for information only. They are not buy or sell recommendations.